Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Am J Obstet Gynecol. 2016 Jul 11;215(6):758.e1–758.e9. doi: 10.1016/j.ajog.2016.07.012

Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women

Leah HAWKINS BRESSLER 1, Lia A BERNARDI 1, Peter John D DE CHAVEZ 2, Donna D BAIRD 3, Mercedes R CARNETHON 2, Erica E MARSH 1,*
PMCID: PMC5124512  NIHMSID: NIHMS820581  PMID: 27418446

Abstract

Background

While alcohol consumption and cigarette smoking are common behaviors in reproductive-age women, little is known about the impact of consumption patterns on ovarian reserve. Even less is known about the effects of smoking and alcohol use in reproductive age African-American women.

Objective

To examine the impact of patterns of alcohol intake and cigarette smoking on anti- Müllerian hormone levels as a marker of ovarian reserve in African-American women.

Study Design

Cross-sectional analysis from the baseline clinical visit and data collection of the Study of Environment, Lifestyle and Fibroids performed by the National Institute of Environmental Health Sciences. A total of 1,654 volunteers, aged 23–34 years, recruited from the Detroit, Michigan community completed questionnaires on alcohol intake and cigarette smoking and provided serum for anti-Müllerian hormone measurement. Multivariable linear and logistic regression were used as appropriate to estimate the effect of a range of exposure patterns on anti-Müllerian hormone levels while adjusting for potential confounders including age, body mass index and hormonal contraception.

Results

Most participants were alcohol drinkers (74%). Of those, the majority (74%) engaged in binge drinking at least once in the last year. Women who reported binge drinking twice weekly or more had 26% lower anti-Müllerian hormone levels compared to current drinkers who never binged (CI: −44, −2, P<0.04). Other alcohol consumption patterns (both past and current) were unrelated to anti-Müllerian hormone. The minority of participants currently (19%) or formerly (7%) smoked and only 4% of current smokers used a pack a day or more. Neither smoking status nor secondhand smoke exposure in utero, childhood or adulthood was associated with anti-Müllerian hormone levels.

Conclusion

Results suggest that current, frequent binge drinking may adversely impact ovarian reserve. Other drinking and smoking exposures were not associated with anti-Müllerian hormone in this cohort of healthy, young African-American women. Longitudinal study of how these common lifestyle behaviors impact variability in age-adjusted anti-Müllerian hormone levels is merited.

Keywords: alcohol, anti-Müllerian hormone, cigarette smoking, ovarian reserve, secondhand smoke

Introduction

Anti-Müllerian hormone (AMH) is a marker of ovarian reserve widely used in clinical practice13 and increasingly used as a tool in epidemiologic studies of potential ovarian toxicants.46 Despite educational campaigns on associated health risks, excessive alcohol consumption and cigarette smoking remain frequent behaviors in the U.S.7 Heavy alcohol consumption is increasingly common in reproductive-age women8, even those seeking conception9, and has been associated with decreased in vitro fertilization (IVF) cycle success.10 Cigarette smoking has established adverse effects on short and long-term fertility1113 yet remains a common practice in the U.S., where 1 in 5 women smoke.14 Accordingly, whether alcohol intake and smoking behaviors influence fertility is a question of significant public health concern.9, 10

Existing literature on alcohol intake and AMH levels is limited and suggests a possible differential impact of alcohol on AMH levels by ethnicity. Studies failed to identify a relationship with drinking and AMH levels15 or antral follicle count (AFC) in predominantly Caucasian cohorts16 but suggest worse ovarian reserve testing among black South African women17 and Japanese women18 who drink. Disparate results may be attributable to racial differences in AMH19, cultural differences in alcohol consumption not reflected by the exposure variables ascertained, or methodological differences in characterizing the exposure.20

Evaluation of the impact of cigarette smoking on AMH levels has also produced discordant findings suggesting a differential impact by age. Among perimenopausal women, current smoking was associated with lower AMH levels.21, 22 While one large study identified an inverse, dose-dependent association of smoking with AMH levels15, other investigations failed to reproduce an association between current smoking and AMH levels.16, 23, 24 The influence of passive smoke exposure on AMH has been sparsely studied but one investigation demonstrated lower AMH levels among healthy black South African women who reported passive smoke exposure.17

To characterize the influence of these common lifestyle exposures on ovarian reserve in the understudied African-American population, we assessed the duration, frequency, amount and pattern of use (e.g. binge drinking, cumulative alcohol exposure, cigarettes per day, and passive smoke exposure in utero, childhood and adulthood). We hypothesized that increased frequency and duration of alcohol consumption, cigarette smoking and secondhand smoke exposure would be associated with lower AMH levels.

Materials and Methods

Study Participants

A volunteer community sample of 1,696 African-American women in the Detroit, Michigan area were enrolled in an ongoing prospective cohort study, the Study of Environment, Lifestyle and Fibroids (SELF), whose primary objective is to study the incidence of fibroids in African-American women. Participants were 23 through 34 years of age at the time of recruitment and without a known history of uterine leiomyomata at the time of examination from November 2010 through December 2012. Recruitment and data collection procedures have been previously described.25, 26 Women with a history of hysterectomy, autoimmune disease or any cancer treated with radiation or chemotherapy were excluded.

Eligible participants who completed telephone interviews, all enrollment questionnaires and a clinic visit were enrolled. Participants provided written informed consent. The study was approved by the institutional review boards of the National Institute of Environmental Health Services and the Henry Ford Health System.

Exposure Ascertainment

Data on patient demographics, reproductive and medical histories were self-reported. Participants provided information on drinking, smoking and passive smoke exposure via self-administered computer-assisted web interviewing (CAWI) questionnaires created specifically for use in the SELF study.25, 26 Comprehensive questionnaires assessed the duration, frequency and amount of alcohol consumption, cigarette smoking and secondhand smoke exposure both currently, defined as within the last year, and at the time of maximum consumption.

Women answered questionnaires regarding alcohol intake, including history of regular drinking, age of initiation, number of drinks consumed in the last year and when drinking the most based on frequency of drinking and number of drinks consumed on days of consumption, frequency of binge drinking (4 or more drinks at single occasion) in last year and when drinking the most.” Women were categorized as ever drinkers if they reported a history of drinking at least 10 drinks in any one year and current drinkers if they reported drinking at least 10 drinks in the last year. Binge drinking was defined as consumption of four or more drinks on one occasion.27

Consumption level was categorized as low (drinking less than once a week and never binging), moderate (drinking up to 2 days per week or binge drinking no more than monthly) and heavy (drinking more than 2 days per week or binging twice monthly or more). Cumulative alcohol exposure was denoted by level of consumption (low, moderate, high) and duration of drinking (years). In women with a history of heavy alcohol consumption, the impact of current drinking was assessed to evaluate the permanence of any association with heavy drinking and AMH levels.

Smoking questionnaires assessed history of ever smoking, age of initiation, age of cessation for past smokers, current number of cigarettes smoked per day as well as number of cigarettes smoked per day at the time of heaviest consumption. Regular smoking was defined as smoking at least 1 cigarette per day for more than 6 months. Participants answered questions regarding secondhand, or passive, smoke exposure, including caregiver smoked in home in childhood, number of years living with smoker in childhood, in utero smoke exposure, current passive smoke exposure in the home, proportion of time in adulthood living with smoker in home, and total number of hours per week when participant can smell tobacco smoke. Passive exposure to smoke in utero, childhood and adulthood were also assessed. To capture the impact of secondhand smoke as both an isolated and cumulative smoke exposure, passive exposure was separately assessed in non-smokers and again in all women.

Participants provided serum for AMH measurement during their clinic visit. Cycle day was not included in our analysis due to the low inter- and intra-cycle variability with AMH. 24 Stored serum aliquots were assayed at the Clinical Laboratory Research Core within the Pathology Department at Massachusetts General Hospital. Serum AMH was measured using the picoAMH ELISA (lower limit of detection 0.0016 ng/ml, 1 ng/ml=7.14 pmol/l) (Ansh Labs, Webster, TX). Samples were run at a 1/10 dilution, then neat for the samples that were low. AMH values that remained below the lower limit of detection (n=3) were assigned a value of 0.0011 ng/mL using an established formula.28 The AMH ELISA has intra- and interassay coefficients of variation 6.9% and 6.5% respectively.

Statistical Analysis

The relationship among alcohol consumption variables and AMH levels in the cohort were assessed using multivariable-adjusted linear and logistic regression models. AMH levels were log-transformed to account for non-normal distribution and all models were adjusted for age, BMI, and current hormonal contraception (HC), variables that were previously shown to be significantly associated with AMH levels in this cohort. 29 Recognizing the non-linear association between age and ovarian reserve, main effects models included both an age and an age quadratic term. Considering the natural, age-related decline in AMH levels occurring at 25 years,3031 sensitivity analyses were performed to examine interactions between age and exposure variables. This allowed for an age-related decline in AMH to differ between exposed compared to unexposed participants. Because non-drinkers may represent a highly selected group in the U.S., as suggested by a J-shaped distribution for the effects of alcohol on adverse health outcomes32, a separate analysis was restricted to current drinkers, as has been done in previous investigations33.

Linear regression models with log AMH as the dependent variable generated adjusted estimates of β associated with each exposure of interest. Percent differences and 95% confidence intervals (CIs) in serum AMH between exposure groups were calculated from the βs as follows ([exp(β) −1] *100) and presented with corresponding 95% confidence intervals (CIs) or p-values. Significant associations in linear regression models were further explored in multivariable-adjusted logistic regression models to assess odds of diminished ovarian reserve (DOR), defined as AMH <1, and CIs.

All analyses were carried out using Statistical Analysis Software version 9.4 (SAS Institute, Cary, NC). Continuous variables are presented as means or medians with (standard deviation or interquartile ranges). Potential confounders were assessed using simple linear regression and were considered for addition to the final model if they changed the risk ratio by more than 10%34. Statistical significance was assumed for p<0.05.

Results

A total of 1,654 reproductive-aged African-American women submitted comprehensive questionnaires on alcohol consumption and provided serum for AMH measurement. The mean age of participants was 29 years, median serum AMH concentration was 3.2 ng/mL, and most women were obese with a median BMI of 32 kg/m2. Additional demographic details are presented in Table 1 and median AMH levels by age are presented in Figure 1.

Table 1.

Demographic characteristics 1,654 reproductive-aged African-American women

Demographic characteristic N=1654 (100)a

AMH, ng/mL (median, IQR; range) 3.2, 1.7–5.3; <0.002–39

Ageb, y (mean ±SD; range) 29 ± 4; 23–35

Body mass index, kg/m2 (median, IQR; range)c 32, 26–40; 16–79

Education (%)
 High school or less 367 (22)
 Some college, but no degree 623 (38)
 Bachelor’s, associate or graduate degree 663 (40)

Mean number of pregnanciesd (mean ±SD range) 3 ± 2; 1–15

Current contraception use (%) 454 (27)

History of polycystic ovarian syndrome (%) 52 (3)

Drinking
 Never 438 (26)
 Ever 1216 (74)
  Former 48 (3)
  Current 1168 (71)

Smoking
 Never 1213 (73)
 Former 123 (7)
 Current 318 (19)
  <10 cig/day 233 (14)
  10–14 cig/day 57 (3)
  15+ cig/day 28 (2)

In utero smoke exposuree
 Yes 160 (13)
 No 1053 (87)

Childhood smoke exposure f
 Yes 633 (55)
 No 513 (45)

Current secondhand smoke exposure g
 Yes 204 (17)
 No 1008 (83)

Regression model adjusted for age, age2, BMI and hormonal contraception use.

a

No. (%) = 1654(100), unless otherwise indicated. Column totals may not sum to 100% due to rounding.

b

Women ages 23–34 were recruited; some were 35 by the time all baseline activities and enrollment were completed.

c

Nine women missing

d

Among 1212 gravid women

e

Among 1213 never smokers

f

Among 1146 never smokers; 67 missing

g

Among 1212 never smokers; 1 missing

Figure 1.

Figure 1

Median AMH (ng/mL) by age (years) (n=1654)

Alcohol consumption

The majority (74%) of participants reported current (71%) or former (3%) drinking. The average age of drinking initiation was 20(±3.3) years and most drinkers (84%) reported their heaviest consumption occurred after their teen years. Of all participants, 25% reported weekly or more frequent drinking and 54% reported binge drinking in the last year. When analysis was restricted to women who currently drink (n=1168), most (74%) reported binge drinking in the last year and of these, 26% reported binging multiple times per month.

When drinkers and non-drinkers (reference category) were compared, there were no significant associations between AMH levels and any of the numerous drinking behaviors assessed, including past and current behaviors (Table 2). This included no association of current alcohol intake with AMH levels among women with a history of prior heavy alcohol intake. However, those who binge drank twice a week or more had a 21% lower AMH level compared to those who never drink (CI: −41, 7) (Table 2).

Table 2.

Associations of alcohol intake on anti-Müllerian hormone (AMH) levels among 1,654 reproductive-aged African American women

Alcohol variables Descriptive statistics % Δ in AMHb (95% CI)c

Total Sample N=1654 (100)

Drinking status
 Ever drinkers 1216 (74) 3 (−8, 16)
  Current drinkers 1168 (71) 3 (−9, 16)
  Former drinkers 48 (3) 8 (−22, 49)
 Never drinkers 438 (26) Referent

Alcohol intake during years drank
 Heavy 330 (20) 0 (−14, 17)
 Medium 755 (46) 4 (−9, 18)
 Low 131 (8) 8 (−13, 33)
 Never drinkers 438 (27) Referent

Cumulative alcohol exposurea
 Heavy intake, ≥10 years 118 (7) 3 (−18, 28)
 Heavy intake, 5–9 years 104 (6.5) −7 (−26, 18)
 Heavy intake, 1–4 years 108 (7) 4 (−17, 32)
 Medium intake, ≥10 years 143 (9) 7 (−14, 31)
 Medium intake, 5–9 years 247 (15) −4 (−19, 14)
 Medium intake, 1–4 years 365 (22) 8 (−7, 25)
 Low intake, ≥10 years 8 (0.5) −6 (−56, 101)
 Low intake, 5–9 years 22 (1) 6 (−34, 69)
 Low intake, 1–4 years 101 (6) 9 (−14, 38)
 Never drinkers 438 (26) Referent

Current vs. Never drinkers N=1606 (97)

Current intake
 Heavy 347 (22) −1 (−15, 16)
 Medium 562 (35) 6 (−8, 21)
 Low 259 (16) 3 (−13, 22)
 Never drinkers 438 (27) Referent

Binging in last year
 2 or more times per week 58 (4) −21 (−41, 7)
 Once a week 63 (4) 20 (−10, 61)
 2 to 3 times per month 189 (12) −1 (−18, 20)
 Once a month or less 556 (35) 7 (−6, 23)
 None 302 (19) 0 (−15, 17)
 Never drinkers 438 (27) Referent

Current intake in past heavy drinkersa N=1108
 Heavy past, heavy current 330 (30) 0 (−15, 18)
 Heavy past, medium current 242 (22) 1 (−16, 21)
 Heavy past, low current 98 (9) 8 (−17, 39)
 Never drinkers 438 (40) Referent

Low: drink ≤ weekly, never binge; Medium: drink ≤ twice weekly, binge ≤ monthly; Heavy: drink > twice weekly, binge > monthly

a

Among 670 women with a history of heavy past drinking and 438 never drinkers

b

Calculated using following formula: [exp(β) −1] *100.

c

Multivariable-adjusted model adjusted for age, quadratic age2, BMI and hormonal contraception use

When analyses were limited to current drinkers, the influence of high frequency binging on AMH levels was stronger. Among women who reported binge drinking twice weekly or more frequently had 26% lower AMH levels compared to current drinkers who never binged (CI: −44, −2; P=0.036, Figure 1). This did not translate to increased odds of diminished ovarian reserve (OR: 0.85, CI: 0.5–2.7, P=0.39). Figure 1 demonstrates associations between binge drinking patterns and AMH levels among current drinkers. There was no association with teenage drinking, frequency or duration of drinking, current heavy drinking or ever binging (results not presented).

Cigarette smoking

Most women (73%) never smoked regularly, 7% formerly smoked and 19% were current smokers. Among current smokers, only 4% smoked a pack or more a day. The average age of smoking initiation was 18(±4) years, cessation was 25(±4) years and average duration of smoking was 6(±5) years, none of which were associated with AMH levels (all P>0.05, Table 3).

Table 3.

Associations of cigarette smoking and secondhand cigarette smoke exposure on anti-Müllerian hormone (AMH) levels among 1,654 reproductive-aged African American women

Cigarette smoking variables Descriptive statistics % Δ in AMH (95% CI)e

Total Sample N=1654 (100)

Smoking status (%)
 Current 318 (19) 1.9 (−−11.0, 16.6)
 Former 123 (7) 7.5 (−12.2, 31.7)
 Never 1213 (73) Referent

Age at initiation of smoking (%)
 15 or younger 82 (5) 9.2 (−14, 39)
 15–18 175 (11) 9.7 (−8, 30)
 19–20 71 (4) −3.2 (−25, 26)
 21–23 74 (5) 3.0 (−20, 33)
 24 and over 39 (2) −20.0 (−44, 14)
 Never smokers 1213 (73) Referent

Current smokers N=1531 (93)

Current consumption
 < 10 233 (15) −1 (−16, 15)
 10–14 57 (4) 10 (−18, 48)
 15–19 16 (1) 32 (−24, 126)
 ≥ 20 12 (1) −7 (−50, 74)
 Never smokers 1213 (79) Referent

Max consumption (cig/day)
 < 10 179 (12) −2 (−17, 17)
 10−14 58 (4) 5 (−22, 40)
 15−19 44 (3) 18 (−16, 64)
 ≥ 20 37 (2) −3 (−33, 39)
 Never smokers 1213 (79) Referent

Years of smoking (y)
 < 1 6 (0.4) 46 (−44, 283)
 1–2 14 (1) −40 (−66, 8)
 3+ 298 (19) 4 (−10, 19)
 Never smokers 1213 (79) Referent

Former smokers N=1336 (81)

Max consumption (cig/day)
 < 10 96 (7) 8 (−15, 37)
 ≥ 10 27 (2) 7 (−30, 64)
 Never smokers 1213 (91) Referent

Years of smoking (y)
 < 1 7 (1) −13 (−62, 99)
 1–2 31 (2) −1 (−33, 48)
 3+ 84 (6) 14 (−11, 46)
 Never smokers 1213 (91) Referent

Never smokers N=1213 (73)

In utero exposure
 Yes or probably yes 160 (13) 5 (−13, 28)
 No or probably no 1053 (87) Referent

Childhood secondhand smoke exposurea
 Yes 633 (55) 9 (−5, 25)
 No 513 (45) Referent

Childhood years living with smoker(s) 91 (8) 12 (−13, 44)
 1 year 65 (5) −12 (−34, 19)
 2 years 42 (4) 29 (−10, 86)
 3 years 67 (6) −2 (−26, 31)
 4–6 years 54 (4) −11 (−34, 25)
 7–9 years 373 (31) 11 (−5, 29)
 10+ years 521 (43) Referent
 None

Time as adult living with smoker in home
 Very little of the time 241 (20) 11 (−6, 32)
 Less than half the time 123 (10) 10 (−12, 37)
 More than half the time 190 (16) 7 (−12, 28)
 None of the time 659 (54) Referent

Currently lives with smoker in homeb
 Yes 204 (17) −1 (−17, 18)
 No 1008 (83) Referent

Time able to currently smell smoke (hours/day)
 < 1 533 (44) 4 (−10, 21)
 1 154 (13) 1 (−19, 25)
 2 23 (2) −1 (−39, 59)
 3–4 54 (4) 1 (−27, 40)
 5−9 40 (3) −5 (−34, 38)
 10+ 18 (1) −31 (−60, 20)
 Unexposed 391 (32) Referent
a

Sixty-seven women missing

b

One woman missing

c

Multivariable-adjusted model adjusted for age, age2, BMI and hormonal contraception use.

Secondhand smoke exposure

When assessing the influence of environmental smoke exposure in never smokers, main results demonstrate no association between AMH levels and in utero, childhood and current secondhand exposure (all P>0.05, Table 3). There was no significant association for high passive smoke exposure as measured by the number of hours per day smelling smoke (31% lower for women with 10+ hours compared to those with none, CI −60, 20). Relationships remained nonsignificant when the analysis sample was expanded to include smokers rather than being limited to non-smokers (results not presented).

Age sensitivity analyses

Sensitivity analyses showed no significant exposure effects on the age-related rate of AMH decline for drinking and smoking-related variables (data not shown).

Comment

This work assessed the influence of patterns of alcohol consumption, cigarette smoking and passive smoke exposure on ovarian reserve as measured by AMH levels35 in reproductive-aged African-American women. Major findings include an inverse association with frequent binging and AMH levels in current drinkers. To our knowledge this is the first study to evaluate the impact of alcohol consumption and cigarette smoking on AMH levels in this demographic and the first in any population to evaluate how patterns of exposure to alcohol (e.g. binge drinking) and cigarette smoke (e.g. passive childhood and in utero smoke exposure) influence AMH. The comprehensive questionnaire permitted detailed assessment of current and former consumption patterns. Findings imply that current, frequent binge drinking may adversely impact AMH levels but that less heavy drinking, cigarette smoking and passive smoke exposure do not influence AMH levels in a cohort of healthy, young African-American women.

Though the impact of binge drinking on AMH has not been previously assessed, our finding of lower AMH levels in frequent binge drinkers is consistent with a Japanese study demonstrating worse ovarian function in current heavy drinkers18. Loss of significance when comparing frequent binge drinkers to never drinkers may reflect an “unhealthy non-drinker” effect33, 36. On the other hand, the number of women with heavy exposure was small, and there was no suggestion of a dose-response, so the association may be a chance finding. However, there is biological plausibility for the detrimental effects of binging. Acute alcohol ingestion has been associated with increased estradiol levels37 and gonadotropins are cleared by the liver38 such that alcohol-induced alterations in hepatic catabolism of estradiol or gonadotropins may impact hypothalamic-pituitary axis signaling. Alternatively, repeated large volume alcohol exposures may overwhelm the protective mechanisms of the granulosa complex.39 In our study population, AMH levels began declining at 25 years of age, in keeping with previous studies, such that that binge drinking in the late twenties might accelerate the natural decline of AMH.2931, 40 Considering that binge drinking is common in young women in the U.S.,7 this finding is important to examine further.

The null associations between a wide range of alcohol drinking behaviors and AMH levels are in keeping with prior studies that failed to identify associations of AMH levels with ever drinking, daily consumption and number of drinks per day in Caucasian women.15, 16 Null associations between alcohol consumption patterns and AMH levels may reflect the durability of the protective mechanisms of the granulosa cells in reproductive-age women.39 It is plausible that current heavy, alcohol consumption negatively impacts fertility and IVF outcomes10 but that this impact is temporary in the absence of repeated large volume exposures sufficient to cause permanent liver damage. Our finding that prior heavy alcohol intake was not associated with AMH levels but that current frequent binge drinking is associated with lower AMH levels supports this assertion, though future investigation assessing AMH levels by current drinking status among women with a history of frequent binge drinking is merited.

With regard to smoking, our results provide a detailed assessment of the impact of active and passive smoking in young women but are limited by small numbers of heavy smokers. Findings of the present work are consistent with studies that failed to identify a relationship with current smoking and AMH levels in young, healthy women.6, 21, 23, 24 On the other hand, studies in late reproductive-age and perimenopausal women15, 21 demonstrate decreased AMH levels in current smokers. Consistent with prior research demonstrating that menopause occurred 0.3–1.2 years earlier in middle-aged smokers,41 a recent genomic study identified an increased rate of follicular decline in middle-aged smokers, and used this finding to argue that an increased rate of follicular decline due to smoking might only be evident at mid-life.22 Considering the well-established relationship of smoking on premature ovarian aging4244 it’s plausible that smoking is associated with ovarian aging but that this is either not evident in younger women based on AMH or was not detected due to a low frequency of heavy smoking in our cohort.

Strengths of this study included novel investigation of the impact of alcohol intake and cigarette smoking on AMH levels in healthy, reproductive-aged African-American women. Comprehensive questionnaires permitted detailed characterization of exposure. Prevalence of lifestyle behaviors in our population was comparable to national estimates including prevalence of current drinking (71 vs. 80%, respectively), binge drinking (current smoking (19% vs. 18%),14 suggesting external validity. A large sample size further allows for external validity within the reproductive-aged female African-American population.

Limitations included cross-sectional analysis and use of a single ovarian reserve marker. However, AMH was measured using a sensitive and reliable (<7% coefficient of variation) assay and studies show high correlation between antral follicle counts and AMH.45 The SELF study was not initially powered to detect associations between alcohol intake and AMH. Consequently, we cannot be certain whether our null associations are attributable to an actual lack of association or to inadequate statistical power. An entirely African-American study population preserves internal validity, fills a gap in the AMH literature that predominantly involves white women but may limit generalization to populations with other demographic compositions. Our self-reported data introduces the possibility of under-reporting (social desirability bias), though this was reduced by the use of a self-administered computer-assisted web interviewing questionnaire46 In addition, self-reported smoking data has been validated previously with serum cotinine measures for both African-Americans and Caucasians4748. Alcohol intake was collected with both the computer-assisted web interview (CAWI) developed for SELF and the web-based Block 2005 Food Frequency Questionnaire49 and these surveys were completed at different times for most women. For analysis, data from the CAWI was used because the alcohol questions were more extensive and response categories allowed for reporting of higher alcohol intake. Still, the correlation between the two surveys for number of drinks per month during the past year was 0.75, indicating good reliability.

This study found that AMH levels were 26% lower in women who engage in current, frequent binge drinking even after adjustment for age, BMI, and hormone use. Other patterns of current and past alcohol consumption, cigarette smoking and smoke exposure were not associated with AMH. Remaining gaps in knowledge include assessment of whether threshold levels of exposure exist above which ovarian protective mechanisms are overwhelmed and whether the impairment in ovarian reserve as a result of repeated binge drinking represents a temporary insult, as our results suggest, or rather a permanent reduction in ovarian reserve. Reproduction of results in prospective investigations would confirm the findings presented herein. The study of longitudinal changes in AMH as a result of lifestyle factors would inform the transience of permanence of such associations over time and better characterize the impact of these common lifestyle behaviors on ovarian reserve.

Figure 2.

Figure 2

Binge drinking pattern and AMH levels among 1168 current drinkers

Frequent binge: binge drinking at least twice weekly vs never bingers

Weekly binge: binge drinking at least once a week vs never bingers

Biweekly binge: binge drinking at least every 2 weeks vs never bingers

Monthly binge: binge drinking monthly or less vs never bingers

Acknowledgments

Source(s) of Funding: National Institutes of Health Grant R21HD077479-01; National Institutes of Health Grant K12HD050121-Northwestern University Women’s Reproductive Health (WRHR) Scholar Award; Harold Amos Medical Faculty Development Award-Robert Wood Johnson Foundation, Friends of Prentice, Evergreen invitational, Woman’s Board. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences and in part by funds allocated for health research by the American Recovery and Reinvestment Act.

We thank Dr. Patrick Sluss and the Clinical Laboratory Research Core in the Pathology Department at Massachusetts General Hospital for performing the assays used in this study. We thank Freya Kamel, who reviewed an earlier draft of the manuscript. We thank Dr. Ganesa Wegienka, Primary Investigator at Henry Ford Health System (HFHS), study manager Dr. Christie Barker-Cummings and the staff at Social and Scientific Systems, HFHS study manager, Karen Bourgeois and her staff at HFHS as well as our research assistants, administrative assistants, and the many others who made this study possible, especially the study participants.

Footnotes

Conflicts of Interest: Consultant for Allergan (EEM); other authors report no conflict of interest

These findings were presented as an oral presentation at the 71st Annual Meeting of the American Society for Reproductive Medicine in Baltimore, Maryland, October 17-21, 2015 (alcohol consumption variables) and as an oral presentation at the 63rd Annual Meeting of the Society for Reproductive Investigation in Montreal, Canada (Quebec Province), March 16-19, 2016 (cigarette smoking variables).

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update. 2010;16(2):113–30. doi: 10.1093/humupd/dmp036. [DOI] [PubMed] [Google Scholar]
  • 2.Broer SL, Eijkemans MJ, Scheffer GJ, et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96(8):2532–9. doi: 10.1210/jc.2010-2776. [DOI] [PubMed] [Google Scholar]
  • 3.Steiner AZ, Herring AH, Kesner JS, et al. Antimullerian hormone as a predictor of natural fecundability in women aged 30–42 years. Obstet Gynecol. 2011;117(4):798–804. doi: 10.1097/AOG.0b013e3182116bc8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Baird DD, Steiner AZ. Anti-Mullerian hormone: a potential new tool in epidemiologic studies of female fecundability. American journal of epidemiology. 2012;175(4):245–9. doi: 10.1093/aje/kwr439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nelson SM, Messow MC, Wallace AM, et al. Nomogram for the decline in serum antimullerian hormone: a population study of 9,601 infertility patients. Fertility and sterility. 2011;95(2):736–41. e1–3. doi: 10.1016/j.fertnstert.2010.08.022. [DOI] [PubMed] [Google Scholar]
  • 6.Shaw CM, Stanczyk FZ, Egleston BL, et al. Serum antimullerian hormone in healthy premenopausal women. Fertility and sterility. 2011;95(8):2718–21. doi: 10.1016/j.fertnstert.2011.05.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.(SAMHSA) SAaMHSA. 2013 National Survey on Drug Use and Health (NSDUH). Table 2.41B—Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2012 and 2013. 2013 [Google Scholar]
  • 8.Dwyer-Lindgren L, Flaxman AD, Ng M, et al. Drinking Patterns in US Counties From 2002 to 2012. American journal of public health. 2015;105(6):1120–7. doi: 10.2105/AJPH.2014.302313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gormack AA, Peek JC, Derraik JG, et al. Many women undergoing fertility treatment make poor lifestyle choices that may affect treatment outcome. Human reproduction. 2015;30(7):1617–24. doi: 10.1093/humrep/dev094. [DOI] [PubMed] [Google Scholar]
  • 10.Rossi BV, Berry KF, Hornstein MD, et al. Effect of alcohol consumption on in vitro fertilization. Obstet Gynecol. 2011;117(1):136–42. doi: 10.1097/AOG.0b013e31820090e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Human reproduction. 1998;13(6):1532–9. doi: 10.1093/humrep/13.6.1532. [DOI] [PubMed] [Google Scholar]
  • 12.Kee K, Flores M, Cedars MI, et al. Human primordial germ cell formation is diminished by exposure to environmental toxicants acting through the AHR signaling pathway. Toxicological sciences : an official journal of the Society of Toxicology. 2010;117(1):218–24. doi: 10.1093/toxsci/kfq179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Soldin OP, Makambi KH, Soldin SJ, et al. Steroid hormone levels associated with passive and active smoking. Steroids. 2011;76(7):653–9. doi: 10.1016/j.steroids.2011.02.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jamal A, Agaku IT, O'Connor E, et al. Current cigarette smoking among adults--United States, 2005–2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1108–12. [PMC free article] [PubMed] [Google Scholar]
  • 15.Dolleman M, Verschuren WM, Eijkemans MJ, et al. Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98(5):2106–15. doi: 10.1210/jc.2012-3995. [DOI] [PubMed] [Google Scholar]
  • 16.Nardo LG, Christodoulou D, Gould D, et al. Anti-Mullerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history. Gynecol Endocrinol. 2007;23(8):486–93. doi: 10.1080/09513590701532815. [DOI] [PubMed] [Google Scholar]
  • 17.Whitworth KW, Baird DD, Steiner AZ, et al. Anti-Mullerian Hormone and Lifestyle, Reproductive, and Environmental Factors Among Women in Rural South Africa. Epidemiology. 2015;26(3):429–35. doi: 10.1097/EDE.0000000000000265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Li N, Fu S, Zhu F, et al. Alcohol intake induces diminished ovarian reserve in childbearing age women. J Obstet Gynaecol Res. 2013;39(2):516–21. doi: 10.1111/j.1447-0756.2012.01992.x. [DOI] [PubMed] [Google Scholar]
  • 19.Gleicher N, Kim A, Weghofer A, et al. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol. 2012;10:77. doi: 10.1186/1477-7827-10-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.VanderWeele TJ, Chen Y, Ahsan H. Inference for causal interactions for continuous exposures under dichotomization. Biometrics. 2011;67(4):1414–21. doi: 10.1111/j.1541-0420.2011.01629.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Plante BJ, Cooper GS, Baird DD, et al. The impact of smoking on antimullerian hormone levels in women aged 38 to 50 years. Menopause. 2010;17(3):571–6. doi: 10.1097/gme.0b013e3181c7deba. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Schuh-Huerta SM, Johnson NA, Rosen MP, et al. Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women. Human reproduction. 2012;27(2):594–608. doi: 10.1093/humrep/der391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dafopoulos A, Dafopoulos K, Georgoulias P, et al. Smoking and AMH levels in women with normal reproductive history. Arch Gynecol Obstet. 2010;282(2):215–9. doi: 10.1007/s00404-010-1425-1. [DOI] [PubMed] [Google Scholar]
  • 24.La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Human reproduction. 2007;22:766–71. doi: 10.1093/humrep/del421. [DOI] [PubMed] [Google Scholar]
  • 25.Moore KR, Cole SR, Dittmer DP, Schoenbach VJ, Smith JS, Baird DD. Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women. Journal of women's health. 2015;24(6):489–95. doi: 10.1089/jwh.2014.5051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Baird DD, Harmon QE, Upson K, et al. A Prospective, Ultrasound-Based Study to Evaluate Risk Factors for Uterine Fibroid Incidence and Growth: Methods and Results of Recruitment. J Womens Health (Larchmt) 2015 doi: 10.1089/jwh.2015.5277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Alcoholism. NIoAAa. Alcohol Facts and Statistics. 2015 Jun 22; http://pubs.niaaa.nih.gov/publications/AlcoholFacts&Stats.htm2015.
  • 28.Hornung RWRL. Estimation of average concentration in the presence of nondetectable values. Applied Occupational and Environmental Hygiene. 1990;5(1):46–51. [Google Scholar]
  • 29.Marsh EE, Bernardi LA, Steinberg ML, de Chavez PJ, Visser JA, Carnethon MR, et al. Novel correlates between antimullerian hormone and menstrual cycle characteristics in African-American women (23–35 years-old) Fertility and sterility. 2016 Apr 23; doi: 10.1016/j.fertnstert.2016.04.008. [Epub ahead of print]". [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370–85. doi: 10.1093/humupd/dmt062. [DOI] [PubMed] [Google Scholar]
  • 31.Lie Fong S, Visser JA, Welt CK, et al. Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012;97(12):4650–5. doi: 10.1210/jc.2012-1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Thune I, Brenn T, Lund E, et al. Physical activity and the risk of breast cancer. The New England journal of medicine. 1997;336(18):1269–75. doi: 10.1056/NEJM199705013361801. [DOI] [PubMed] [Google Scholar]
  • 33.Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. The New England journal of medicine. 1995;332(19):1245–50. doi: 10.1056/NEJM199505113321901. [DOI] [PubMed] [Google Scholar]
  • 34.Greenland S. Modeling and variable selection in epidemiologic analysis. American journal of public health. 1989;79(3):340–9. doi: 10.2105/ajph.79.3.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Committee on Gynecologic P. Committee opinion no. 618: Ovarian reserve testing. Obstet Gynecol. 2015;125(1):268–73. doi: 10.1097/01.AOG.0000459864.68372.ec. [DOI] [PubMed] [Google Scholar]
  • 36.Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. The New England journal of medicine. 1997;337(24):1705–14. doi: 10.1056/NEJM199712113372401. [DOI] [PubMed] [Google Scholar]
  • 37.Mendelson JH, Lukas SE, Mello NK, et al. Acute alcohol effects on plasma estradiol levels in women. Psychopharmacology. 1988;94(4):464–7. doi: 10.1007/BF00212838. [DOI] [PubMed] [Google Scholar]
  • 38.Ben-Rafael Z, Levy T, Schoemaker J. Pharmacokinetics of follicle-stimulating hormone: clinical significance. Fertility and sterility. 1995;63(4):689–700. doi: 10.1016/s0015-0282(16)57467-6. [DOI] [PubMed] [Google Scholar]
  • 39.McKenzie PP, McClaran JD, Caudle MR, et al. Alcohol inhibits epidermal growth factor-stimulated progesterone secretion from human granulosa cells. Alcohol Clin Exp Res. 1995;19(6):1382–8. doi: 10.1111/j.1530-0277.1995.tb00996.x. [DOI] [PubMed] [Google Scholar]
  • 40.Thilagam A. Mathematical modelling of decline in follicle pool during female reproductive ageing. Math Med Biol. 2015 doi: 10.1093/imammb/dqv006. [DOI] [PubMed] [Google Scholar]
  • 41.Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. American journal of epidemiology. 2001;153(9):865–74. doi: 10.1093/aje/153.9.865. [DOI] [PubMed] [Google Scholar]
  • 42.Klonoff-Cohen H. Female and male lifestyle habits and IVF: what is known and unknown. Hum Reprod Update. 2005;11(2):179–203. doi: 10.1093/humupd/dmh059. [DOI] [PubMed] [Google Scholar]
  • 43.Stillman RJ, Rosenberg MJ, Sachs BP. Smoking and reproduction. Fertility and sterility. 1986;46(4):545–66. doi: 10.1016/s0015-0282(16)49628-7. [DOI] [PubMed] [Google Scholar]
  • 44.Mattison DR, Thorgeirsson SS. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet. 1978;1(8057):187–8. doi: 10.1016/s0140-6736(78)90617-7. [DOI] [PubMed] [Google Scholar]
  • 45.Broer SL, Mol BW, Hendriks D, et al. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertility and sterility. 2009;91(3):705–14. doi: 10.1016/j.fertnstert.2007.12.013. [DOI] [PubMed] [Google Scholar]
  • 46.Metzger, Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. Am J Epidemiol. 2000;152:99–106. doi: 10.1093/aje/152.2.99. [DOI] [PubMed] [Google Scholar]
  • 47.Sterling TD, Weinkam JJ. Comparison of smoking-related risk factors among Black and White males. Am J Ind Med. 1989;15:319–333. doi: 10.1002/ajim.4700150307. [DOI] [PubMed] [Google Scholar]
  • 48.Caraballo RS, Giovino GA, Pechacek TF, Mowery PD. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older. Am J Epidemiol. 2001;153:807–14. doi: 10.1093/aje/153.8.807. [DOI] [PubMed] [Google Scholar]
  • 49.Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453–469. doi: 10.1093/oxfordjournals.aje.a114416. [DOI] [PubMed] [Google Scholar]

RESOURCES